An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia

Seminars in Reproductive Medicine

Volumn 30, Issue 5, 2012, Pages 396-399

  New, Mariai ^a,b   Abraham, Moolamannil ^a,b   Yuen, Tony ^a,b   Lekarev, Oksana ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Pediatrics Genetics and Genomic Sciences ^*  (United States)

Author keywords

congenital adrenal hyperplasia; dexamethasone; genital ambiguity; noninvasive prenatal diagnosis; prenatal treatment

Indexed keywords

DEXAMETHASONE; DNA;

AMNIOCENTESIS; ARTICLE; CHORION VILLUS SAMPLING; CLINICAL ASSESSMENT TOOL; COGNITION; CONGENITAL ADRENAL HYPERPLASIA; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PRADER SCORE; PREGNANCY; PRENATAL DIAGNOSIS; PRENATAL PERIOD; SEX DETERMINATION;

ADRENAL HYPERPLASIA, CONGENITAL; DEXAMETHASONE; FEMALE; FETAL THERAPIES; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; MALE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84867013916     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0032-1324723     Document Type: Article

References (11)

1. nd World Conference. New MI, Simpson JL (eds). Springer 2011
2. Hirvikoski T., Nordenström A., Lindholm T., et al. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab: 2007; 92 2 542 548
3. Hirvikoski T., Nordenström A., Lindholm T., Lindblad F., Ritzén E. M., Lajic S. Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems? Eur J Endocrinol: 2008; 159 3 309 316
4. Chan K. C., Lo Y. M. Circulating nucleic acids as a tumor marker. Histol Histopathol: 2002; 17 3 937 943
5. Bischoff F. Z., Nguyen D. D., Marquéz-Do D., Moise K. J. Jr, Simpson J. L., Elias S. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Investig: 1999; 6 2 64 69
6. Lo Y. M., Lau T. K., Zhang J., et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem: 1999; 45 10 1747 1751
7. Farina A., LeShane E. S., Lambert-Messerlian G. M., et al. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem: 2003; 49 2 239 242
8. Johnson K. L., Dukes K. A., Vidaver J., et al. Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin Chem: 2004; 50 3 516 521
9. Wright C. F., Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update: 2009; 15 1 139 151
10. Crouch N. S., Minto C. L., Laio L. M., Woodhouse C. RJ, Creighton S. M. Genital sensation after feminizing genitoplasty for congenital adrenal hyperplasia: a pilot study. BJU Int: 2004; 93 1 135 138
11. Crouch N. S., Liao L. M., Woodhouse C. R., Conway G. S., Creighton S. M. Sexual function and genital sensitivity following feminizing genitoplasty for congenital adrenal hyperplasia. J Urol: 2008; 179 2 634 638